Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims against Nano-X Imaging Ltd. following the company's announcement of a $33.4 million net loss in Q4 2025, largely due to a $17.5 million impairment charge related to restructuring its Korean chip facility. The investigation also follows the announcement that CFO Ran Daniel will resign by July 31, 2026. Nano-X's stock price dropped 24.39% after the news. Investors who suffered losses may contact the law firm for potential legal action.
Alamar Biosciences presented extensive data from its NULISA platform at the AAIC 2026 conference, highlighting advances in blood-based biomarkers for Alzheimer's detection and staging. The company emphasized new findings on eMTBR-Tau and BD-pTau217, ...
Alamar Biosciences announced that its NULISA platform was prominently featured in over 140 scientific presentations at the 2026 Alzheimer's Association International Conference (AAIC) in London, highlighting its growing adoption in Alzheimer's resear...
Holtec Nuclear Corporation has filed a registration statement with the U.S. SEC for a proposed initial public offering (IPO) of its Class A common stock, planning to list on Nasdaq under the symbol "HNUC." The offering details, including share count ...
Audiera (BEAT) surged 16.18% to $2.61, leading altcoin gains driven by its decentralized music streaming platform and innovative artist compensation model. Other notable gainers include MemeCore, Lighter, and DeXe, reflecting growing interest in NFTs...
Kahn Swick & Foti, LLC is investigating Inspire Medical Systems following the company's announcement of delays in launching its Inspire V device and a significant cut in 2025 earnings guidance by over 80%. The delays were due to undisclosed issues su...
